Virax Biolabs VRAX
NASDAQ VRAX
$2.17 -0.07 (-3.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Other Accumulated Expenses (2021 - 2026)

Updated

Virax Biolabs (VRAX) posted Other Accumulated Expenses of $265,982 for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 21.2% from $337,576 a year earlier.

Analysis

Virax Biolabs (VRAX) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

Since fiscal Q4 2021, Virax Biolabs has reported Other Accumulated Expenses for 7 quarters.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -6.4% (FY2021 to FY2026).
  • In prior fiscal years, Virax Biolabs' Other Accumulated Expenses was $337,576 in FY2025, $18,296 in FY2023 (-85.5%) and $126,183 in FY2022 (-66.0%).
  • The fiscal Q4 2026 figure stands as the lowest quarterly Other Accumulated Expenses since fiscal Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Virax Biolabs 862,770.33 -20.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 265,982.00
Mar 31, 2025 337,576.00
Sep 30, 2023 93,462.00
Mar 31, 2023 18,296.00
Sep 30, 2022 23,486.00
Mar 31, 2022 126,183.00
Mar 31, 2021 371,051.00
API Access

Virax Biolabs Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VRAX&period=max&api_key=YOUR_API_KEY